Mostrando resultados 2 a 21 de 28
< Anterior
Siguiente >
| Derechos | Preview | Fecha Public. | Título | Autor(es) | Tipo |
| openAccess |  | 2021 | Bone marrow mesenchymal stromal cells in multiple myeloma: Their role as active contributors to myeloma progression | Maiso, Patricia; Mogollón, Pedro; Ocio, Enrique M. CSIC ORCID ; Garayoa, Mercedes CSIC ORCID | artículo de revisión |
| openAccess |  | 2012 | CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype | Paíno, Teresa CSIC ORCID; Ocio, Enrique M. CSIC ORCID ; Paiva, Bruno; San-Segundo, Laura CSIC; Garayoa, Mercedes CSIC ORCID ; Gutiérrez, Norma Carmen; Sarasquete, María Eugenia; Pandiella, Atanasio CSIC ORCID CVN ; Orfao, Alberto CSIC ORCID ; San Miguel, Jesús F. CSIC ORCID | artículo |
| openAccess |  | 2012 | Dasatinib as a bone-modifying agent: Anabolic and anti-resorptive effects | García-Gómez, Antonio; Ocio, Enrique M. CSIC ORCID ; Crusoe, Edvan; Santamaría, Carlos; Hernández-Campo, Pilar M.; Blanco, Juan F.; Sánchez-Guijo, Fermín M. CSIC ORCID; Hernández, Mª Teresa; Pandiella, Atanasio CSIC ORCID CVN ; San Miguel, Jesús F. CSIC ORCID; Garayoa, Mercedes CSIC ORCID ; Briñón, Jesús G. | artículo |
| closedAccess |  | 2019 | Dihydropyrimidine-2-thiones as Eg5 inhibitors and L-type calcium channel blockers: Potential antitumour dual agents | González-Hernández, Elena; Aparicio, Rubén; Garayoa, Mercedes CSIC ORCID ; Montero, María J.; Sevilla, Mª Ángeles; Pérez-Melero, Concepción | artículo |
| closedAccess |  | 2020 | Filanesib for the treatment of multiple myeloma | Algarín, Esperanza M.; Hernández-García, Susana CSIC; Garayoa, Mercedes CSIC ORCID ; Ocio, Enrique M. CSIC ORCID | artículo |
| openAccess |  | 2021 | Immune System Alterations in Multiple Myeloma: Molecular Mechanisms and Therapeutic Strategies to Reverse Immunosuppression | Díaz-Tejedor, Andrea; Lorenzo-Mohamed, Mauro; Puig, Noemi; García-Sanz, Ramón; Mateos, Maria Victoria; Garayoa, Mercedes CSIC ORCID ; Paíno, Teresa CSIC ORCID | artículo |
| openAccess |  | 1-may-2010 | In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma | Ocio, Enrique M. CSIC ORCID ; Vilanova, David; Maiso, Patricia; Crusoe, Edvan; Fernández-Lázaro, Diego CSIC ORCID; Garayoa, Mercedes CSIC ORCID ; San-Segundo, Laura CSIC; Hernández, Mª Teresa; San Miguel, Jesús F. CSIC ORCID | artículo |
| closedAccess |  | 2015 | In vivo murine model of acquired resistance in myeloma reveals differential mechanisms for lenalidomide and pomalidomide in combination with dexamethasone | Ocio, Enrique M. CSIC ORCID ; Fernández-Lázaro, Diego CSIC ORCID; San-Segundo, Laura CSIC; López-Corral, L.; Corchete, Luis A.; Gutiérrez, Norma Carmen; Garayoa, Mercedes CSIC ORCID ; Paíno, Teresa CSIC ORCID; García-Gómez, Antonio; Delgado, Manuel; Montero, Juan Carlos CSIC ORCID; Díaz-Rodríguez, Elena CSIC ORCID CVN; Mateos, Maria Victoria; Pandiella, Atanasio CSIC ORCID CVN ; San Miguel, Jesús F. CSIC ORCID | artículo |
| closedAccess |  | 2009 | Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donorsGenomic profile of multiple myeloma MSCs | Garayoa, Mercedes CSIC ORCID ; García, Juan L. CSIC ORCID CVN ; Santamaría, Carlos; García-Gómez, Antonio; Blanco, Juan F.; Pandiella, Atanasio CSIC ORCID CVN ; Hernández, Jesús M. CSIC ORCID ; Sánchez-Guijo, Fermín M. CSIC ORCID; Cañizo, María Consuelo del; Gutiérrez, Norma Carmen; San Miguel, Jesús F. CSIC ORCID | artículo |
| openAccess |  | 2014 | Phenotypic, genomic and functional characterization reveals no differences between CD138++ and CD138low subpopulations in multiple myeloma cell lines | Paíno, Teresa CSIC ORCID; Sarasquete, María Eugenia; Paiva, Bruno; Krzemiński, Patryk; San-Segundo, Laura CSIC; Corchete, Luis A.; Redondo, Alba; Garayoa, Mercedes CSIC ORCID ; García-Sanz, Ramón; Gutiérrez, Norma Carmen; Ocio, Enrique M. CSIC ORCID ; San Miguel, Jesús F. CSIC ORCID | artículo |
| closedAccess |  | 2014 | Preclinical activity of the oral proteasome inhibitor mln9708 in myeloma bone disease | García-Gómez, Antonio; Ocio, Enrique M. CSIC ORCID ; Blanco, Juan F.; Hernández-Iglesias, Teresa; Fraile, Susana CSIC; San Miguel, Jesús F. CSIC ORCID; Garayoa, Mercedes CSIC ORCID | artículo |
| openAccess |  | 2017 | Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair | López-Iglesias, Ana-Alicia; Herrero, Ana B. CSIC ORCID; Chesi, Marta; San-Segundo, Laura CSIC; González-Méndez, Lorena; Hernández-García, Susana CSIC; Misiewicz-Krzeminska, Irena; Quwaider, Dalia; Martín-Sánchez, Montserrat; Primo, Daniel; Paíno, Teresa CSIC ORCID; Bergsagel, P. Leif; Mehrling, Thomas; González, Marcos CSIC ORCID ; San Miguel, Jesús F. CSIC ORCID; Mateos, Maria Victoria; Gutiérrez, Norma Carmen; Garayoa, Mercedes CSIC ORCID ; Ocio, Enrique M. CSIC ORCID | artículo |
| openAccess |  | 2020 | Preclinical evaluation of the simultaneous inhibition of MCL-1 and BCL-2 with the combination of S63845 and venetoclax in multiple myeloma | Algarín, Esperanza M.; Díaz-Tejedor, Andrea; Mogollón, Pedro; Hernández-García, Susana CSIC; Corchete, Luis A.; San-Segundo, Laura CSIC; Martín-Sánchez, Montserrat; González-Méndez, Lorena; Schoumacher, Marie; Banquet, Sebastien; Kraus-Berthie, Laurence; Kloos, Ioana; Derreal, Alix; Halilovic, Ensar; Maacke, Heiko; Gutiérrez, Norma Carmen; Mateos, Maria Victoria; Paíno, Teresa CSIC ORCID; Garayoa, Mercedes CSIC ORCID ; Ocio, Enrique M. CSIC ORCID | carta al director |
| openAccess |  | 24-sep-2020 | Protein Translation Inhibition is Involved in the Activity of the Pan-PIM Kinase Inhibitor PIM447 in Combination with Pomalidomide-Dexamethasone in Multiple Myeloma | Paíno, Teresa CSIC ORCID; González-Méndez, Lorena; San-Segundo, Laura CSIC; Corchete, Luis A.; Hernández-García, Susana CSIC; Díaz-Tejedor, Andrea; Algarín, Esperanza M.; Mogollón, Pedro; Martín-Sánchez, Montserrat; Gutiérrez, Norma Carmen; Mateos, Maria Victoria; Garayoa, Mercedes CSIC ORCID ; Ocio, Enrique M. CSIC ORCID | artículo |
| closedAccess |  | 2013 | RAF265, a dual BRAF and VEGFR2 inhibitor, prevents osteoclast formation and resorption. Therapeutic implications | García-Gómez, Antonio; Ocio, Enrique M. CSIC ORCID ; Pandiella, Atanasio CSIC ORCID CVN ; San Miguel, Jesús F. CSIC ORCID; Garayoa, Mercedes CSIC ORCID | artículo |
| openAccess |  | feb-2013 | Sphingosine-1-phosphate activates chemokine-promoted myeloma cell adhesion and migration involving α4β1 integrin function | García-Bernal, David CSIC ORCID; Redondo-Muñoz, Javier CSIC ORCID ; Dios-Esponera, Ana CSIC; Chèvre, Raphael; Bailón, Elvira CSIC ORCID; Garayoa, Mercedes CSIC ORCID ; Arellano-Sánchez, Nohemí CSIC ; Gutiérrez, Norma C.; Hidalgo, Andrés CSIC ORCID; García-Pardo, Angeles CSIC ORCID; Teixidó, Joaquín CSIC ORCID | artículo |
| openAccess |  | 2021 | Stroma-Mediated Resistance to S63845 and Venetoclax through MCL-1 and BCL-2 Expression Changes Induced by miR-193b-3p and miR-21-5p Dysregulation in Multiple Myeloma | Algarín, Esperanza M.; Quwaider, Dalia; Campos-Laborie, Francisco J.; Díaz-Tejedor, Andrea; Mogollón, Pedro; Vuelta, Elena; Martín-Sánchez, Montserrat; San-Segundo, Laura CSIC; González-Méndez, Lorena; Gutiérrez, Norma Carmen; García-Sanz, Ramón; Paíno, Teresa CSIC ORCID; De Las Rivas, Javier CSIC ORCID CVN ; Ocio, Enrique M. CSIC ORCID ; Garayoa, Mercedes CSIC ORCID | artículo |
| openAccess |  | 2017 | Synergistic DNA-damaging effect in multiple myeloma with the combination of zalypsis, bor tezomib and dexamethasone | López-Iglesias, Ana-Alicia; González-Méndez, Lorena; San-Segundo, Laura CSIC; Herrero, Ana B. CSIC ORCID; Hernández-García, Susana CSIC; Martín-Sánchez, Montserrat; Gutiérrez, Norma Carmen; Paíno, Teresa CSIC ORCID; Avilés Marín, Pablo; Mateos, Maria Victoria; San Miguel, Jesús F. CSIC ORCID; Garayoa, Mercedes CSIC ORCID ; Ocio, Enrique M. CSIC ORCID | artículo |
| openAccess |  | 2021 | Targeting aberrant DNA methylation in mesenchymal stromal cells as a treatment for myeloma bone disease | García-Gómez, Antonio; Li, Tianlu; Rodríguez-Ubreva, Javier; Ciudad, Laura CSIC ORCID; Català-Moll, Francesc; Godoy-Tena, Gerard; Martín-Sánchez, Montserrat; San-Segundo, Laura CSIC; Muntión, Sandra; Morales, Xabier; Ortiz-de-Solorzano, Carlos; Oyarzabal, Julen; San José-Enériz, Edurne; Esteller, M.; Agirre, Xavier; Prósper, Felipe; Garayoa, Mercedes CSIC ORCID ; Ballestar, Esteban | artículo |
| closedAccess |  | 11-mar-2021 | Targeting anti-apoptotic proteins in multiple myeloma | Garayoa, Mercedes CSIC ORCID | comunicación de congreso |
